Tradestie Institutional Equity Comparison Engine
ECOR vs COCP โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
COCP Overall Edge
COCP Captures Institutional Edge (1โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cocrystal Pharma, Inc. Common Stock (COCP) driven by superior Growth & Margin while ECOR counters with relative strength in Momentum & Technical. Fundamentally, ECOR trades at N/M Forward P/E with -33.1% operating margin (+11.5% YoY revenue) versus COCP at N/M Forward P/E and -2646.0% operating margin (+26.9% YoY). In options structure, ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against COCP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ECOR N/M vs COCP N/M Fwd P/E
Growth & Margin Winner
COCP
Op Margin -33.1% vs -2646.0% ยท YoY +11.5% vs +26.9%
Momentum & Technical Winner
ECOR
1Y -4.0% vs -4.9% ยท 52W Pos 6% vs 16%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ECOR
NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.85
-6.19% 1D
Market Cap
$47.7M
1M Return
-34.01%
1Y Return
-3.96%
Forward P/E
N/M
Unified AI Score
56.8 / 100
HOLD
Tech 68.0
Fund 53.0
Flow 50.0
Mom 64.0
COCP
NASDAQ
Cocrystal Pharma, Inc. Common Stock
Pharmaceutical Preparations
$0.97
-0.72% 1D
Market Cap
$18.5M
1M Return
+2.79%
1Y Return
-4.91%
Forward P/E
N/M
Unified AI Score
45.4 / 100
HOLD
Tech 44.0
Fund 50.0
Flow 50.0
Mom 54.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ECOR -3.96%
COCP -4.91%
Spread: +0.95 pp (ECOR Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ECOR Revenue | COCP Revenue | ECOR Op. Margin | COCP Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | -5494.1% | N/A | ECOR |
| FY2019 | $0M | $10M | -1928.2% | -737.4% | COCP |
| FY2020 | $0M | $0M | -707.9% | -476.0% | COCP |
| FY2021 | $10M | N/A | -367.7% | N/A | ECOR |
| FY2022 | $10M | N/A | -266.2% | N/A | ECOR |
| FY2023 | $20M | N/A | -120.2% | N/A | ECOR |
| FY2024 | $30M | N/A | -48.3% | N/A | ECOR |
| FY2025 | $30M | N/A | -41.1% | N/A | ECOR |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ECOR | COCP | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $47.7M | $18.5M | Larger Scale | ECOR |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +11.5% | +26.9% | Higher Growth | COCP |
| Operating Margin (TTM) Profitability | -33.1% | -2646.0% | Higher Margin | ECOR |
| Net Profit Margin Profitability | -33.5% | 0.0% | Higher Margin | COCP |
| Return on Equity (ROE) Capital Efficiency | -478.7% | -219.1% | Higher ROE | COCP |
| 52-Week Range Position Momentum | 6% ($4โ$13) | 16% ($1โ$2) | Stronger Trend | COCP |
| Beta / 30D Volatility Risk Regime | 1.52ฮฒ ยท 155% Vol | 1.01ฮฒ ยท 55% Vol | Lower Realized Risk | COCP |
| Unified Institutional Score Composite Signal | 56.8 / 100 (HOLD) | 45.4 / 100 (HOLD) | Higher Composite | ECOR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ECOR vs COCP Buy Guide
ECOR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
COCP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ECOR nor COCP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.